黄病毒
登革热病毒
氧化应激
登革热
疾病
医学
生物标志物
脑炎
黄病毒科
日本脑炎
免疫学
病毒学
病毒
生物
病毒性疾病
病理
内科学
生物化学
作者
Maxim Van Herreweghe,Tess De Bruyne,Nina Hermans,Ralph Huits
摘要
ABSTRACT Several Flaviviridae constitute an emerging threat to global health because of their continuing spread and the expansion of vector habitats, largely driven by climate change and intensified global travel. Infections can result in severe neurological or visceral pathologies. The relationship between oxidative stress (OS), an imbalance between generated reactive oxygen species and the antioxidant defences of the host, and flavivirus infection has been repeatedly demonstrated in in vitro and animal studies, but measuring biomarkers of oxidative stress in vivo could prove useful in clinical patient management. We summarise the knowledge and prospects of measuring peripheral OS biomarker levels for clinical case management and correlation with disease severity in six important human flavivirus infections (dengue virus (DENV), Japanese encephalitis virus, West Nile virus (WNV), tick‐borne encephalitis virus (TBEV), yellow fever virus and zika virus). We searched the Medline and Web of Science databases for ‘Oxidative Stress’ AND ‘Biomarkers’ AND ‘Flavivirus’, combined with ‘clinical’, ‘in vivo/in vivo’, ‘patient’ and/or ‘disease’ and included 43 peer‐reviewed publications. Correlation between OS and infection has been studied in all six Flaviviridae , but most clinically relevant data are available for DENV, TBEV and WNV. Plasma protein carbonyls, glutathione peroxidase activity and nitrogen monoxide are promising prognostic markers, but their measurement would benefit from methodological harmonisation. Future studies should investigate a broad range of OS biomarkers as predictors of clinically relevant outcomes. We advocate the validation and use of universal or disease‐specific oxidative stress indexes that incorporate the most significant outcomes into one, easy‐to‐use clinical determinant.
科研通智能强力驱动
Strongly Powered by AbleSci AI